Proprietary Cell-Line Development for High-Titer AAV Manufacturing: Proprietary cell lines offer opportunities for achieving high AAV titers.
| Published in: | BioPharm International Vol. 37; no. 3; pp. 10 - 15 |
|---|---|
| Main Author: | |
| Format: | pictorial Journal Article |
| Published: |
MJH Life Sciences
Mar2024
|
| Online Access: | View this record in EBSCOhost |
| Description not available. |